Neutrophil to lymphocyte ratio and cancer prognosis: an umbrella review of systematic reviews and meta-analyses of observational studies.
Cupp MA, Cariolou M, Tzoulaki I, Aune D, Evangelou E, Berlanga-Taylor AJ. · 2020
Read Neutrophil to lymphocyte ratio and cancer prognosis: an umbrella review of systematic reviews and meta-analyses of observational studies. by Cupp MA, Cariolou M, Tzoulaki I, Aune D, Evangelou E, Berlanga-Taylor AJ. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7678319.txt.
Description
Cupp and co-authors grade the proof linking a blood ratio to cancer outlook. The ratio compares neutrophils, a type of white blood cell, to lymphocytes. A high ratio is thought to signal worse survival. The authors pooled past systematic reviews to judge the claim.
They found 204 meta-analyses from 86 studies. Almost all linked a high ratio to higher risk of poor outcomes. Yet only 60, or 29%, had strong or highly suggestive support. Proof was solid for some cancers and for care with immunotherapy. The authors say the ratio looks promising, but more work must test cause and clinical use.
Catalog record
| CREATOR | Cupp MA, Cariolou M, Tzoulaki I, Aune D, Evangelou E, Berlanga-Taylor AJ. |
|---|---|
| YEAR | 2020 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 78 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |